Assessment of Disease Risk by Targeted Metabolomics
Assessment of Disease Risk
by Targeted Metabolomics
AGEs, amino acids and metabolites, acylcarnitines, choline oxidation pathway, citric acid cycle, microbiota derived, one carbon metabolism, transsulfuration, tryptophan metabolites, urea cycle, others.
C: Choline derivatives. Charged, methylated or sulfur amino acids.
D: Kynurenine pathway and B vitamins.
E: Folate species and catabolites.
H: Lipid-soluble vitamins and long-chain acylcarnitines.
I: Short-, medium-, and long-chain acylcarnitines (under development).
Choice of biomarker panels and analytical platforms can be crucial for the project outcome. Our experts will help you by a pre-analytical evaluation to maximise data quality and quantity at minimal sample consumption.